Pacemaker, défibrillateur et radiothérapie : propositions de conduite à tenir en 2010 en fonction du type de stimulateur cardiaque, du pronostic et du site du cancer

Lambert, P.; Costa, Antoine Da; Marcy, Pierre-Yves; Kreps, S.; Angellier, G.; Marcié, S.; Bondiau, PY; Briand-Amoros, C.; Thariat, J.

doi:10.1016/j.canrad.2010.12.003

Cited by 15 publications

(4 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4 Electromagnetic interference can generate a signal detected as a normal or pathological heart rhythm, leading to pacing inhibition, or inappropriate shock. 5 The system reset may occur. The CIED reprogramming resolves this issue.…”

Section: Discussionmentioning

confidence: 99%

Radiotherapy in patient with an automated implantable cardioverter defibrillator

Allouche¹,

Oumaya

Abidi

2021

J Radiother Pract

View full text Add to dashboard Cite

Introduction: An ever-growing number of patients with implantable cardiac rhythm devices are treated with radiation therapy for cancer and are therefore at risk of device failure. Several medical societies developed recommendations for the management of such patients. We report the case of a 76-year-old patient with an implanted cardioverter defibrillator, treated with external radiotherapy for breast cancer, to test in practice the recommendations on the management of similar cases.

show abstract

Section: Discussionmentioning

confidence: 99%

Radiotherapy in patient with an automated implantable cardioverter defibrillator

Allouche¹,

Oumaya

Abidi

2021

J Radiother Pract

View full text Add to dashboard Cite

show abstract

“…So, the use of IMRT technique might lead to less radiation dose to pacemakers because of reduced use of high energy photon beams [ 5 ] . At the same time, it is a prolonged radiotherapy treatment with more additional fields for a better dose distribution, what might produce the malfunction [ 3 , 7 , 22 ]. Hashii et al and Gelblum et al demonstrated in vitro the higher neutrons production by use of beam energies above 10 MV, what seem to generate the function defects of pacemakers [ 23 , 24 ].…”

Section: Discussionmentioning

confidence: 99%

“…There are no large clinical studies for the determination of the exact radiation level that causes failure of the cardiac pacemaker and ICD. Most radiotherapy departments are using the radiation dose constraints for implanted devices based on the sparse number of the case reports and in vitro studies which occasionally demonstrate different results [ 1 - 3 ]. The American Association of Physicists in Medicine (AAPM) defined the guidelines for the irradiation exposure of the cardiac pacemakers in 1994 [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

“…These guidelines cover the recommendations for the irradiation of ICDs and consider the modern radiotherapy techniques such as intensity modulated radiation therapy (IMRT) or arc technique. Some investigators demonstrated a predisposition of batteries in modern cardiac pacemakers to quicker or even sudden unloading by an accumulated dose over 5Gy [ 3 , 6 , 7 ] . Radiation exposure of more than 2Gy is rarely found when the location of the heart pacemaker is outside the radiation field [ 8 , 9 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A case of radiotherapy for an advanced bronchial carcinoma patient with implanted cardiac rhythm machines as well as heart assist device

et al. 2015

View full text Add to dashboard Cite

We present a case of radiotherapy for a 66-year-old patient with squamous cell carcinoma on the left main bronchus undergoing implantation of pacemaker, implantable cardioverter defibrillator (ICD) as well as cardiopulmonary support (CPS) device. The radiation area was determined according to 4D List Mode positron emission tomography–computed tomography (PET-CT) data. Planning Target Volume (PTV) included a part of the active ICD. For the optimal tumor coverage and sparing of both the implantable cardiac devices and organs at risk, we combined the conformal radiotherapy with stereotactic body radiotherapy (SBRT) using helical tomotherapy. The prescription dose of 25.2Gy was applied by conventional radiotherapy. SBRT was performed hypofractionated with a prescription dose of 35Gy in 5 fractions. A dynamic electrocardiogram was performed during every radiation fraction. The implanted aggregates were checked three times a week. Despite partial localization of the active ICD in the radiation field, the tumor was treated without inappropriate shock delivery during radiation treatment and over twelve months afterwards. The reduced tumor size as well as tumor metabolic activity were observed by PET-CT three months after radiation treatment. The patient exhibited no signs of pneumonitis on the last radiological follow-up examination six months after radiotherapy. The reduced dyspnea and cough over the first four months after treatment were observed.In conclusion, tumor shrinkage and temporary clinical improvement of the patient as well as no technical complications of implanted cardiac devices were achieved by the radiation treatment.

show abstract

Evidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the Heart

Taylor

Evans

Roberts

2013

Evidence-Based Cardiology Consult

View full text Add to dashboard Cite

Pacemaker, défibrillateur et radiothérapie : propositions de conduite à tenir en 2010 en fonction du type de stimulateur cardiaque, du pronostic et du site du cancer

Cited by 15 publications

References 39 publications

Radiotherapy in patient with an automated implantable cardioverter defibrillator

Radiotherapy in patient with an automated implantable cardioverter defibrillator

A case of radiotherapy for an advanced bronchial carcinoma patient with implanted cardiac rhythm machines as well as heart assist device

Evidence-Based Cardiovascular Management of Patients Receiving Radiotherapy to the Heart

Contact Info

Product

Resources

About